Abernethy DR[au] - Search Results

Year	Number of Results
1972	1
1977	1
1978	1
1981	10
1982	15
1983	33
1984	24
1985	15
1986	16
1987	16
1988	8
1989	6
1990	7
1991	6
1992	4
1993	5
1994	2
1995	3
1996	3
1997	8
1998	6
1999	7
2000	7
2001	2
2002	5
2003	4
2004	5
2005	3
2006	4
2007	7
2008	8
2009	6
2010	7
2011	5
2012	7
2013	2
2014	3
2015	9
2016	4
2017	4
2018	4
2019	3
2022	0

1

Pharmacokinetics and clinical effectiveness of methylphenidate.

Kimko HC, Cross JT, Abernethy DR. Kimko HC, et al. Among authors: abernethy dr. Clin Pharmacokinet. 1999 Dec;37(6):457-70. doi: 10.2165/00003088-199937060-00002. Clin Pharmacokinet. 1999. PMID: 10628897 Review.

2

Effect of obesity on the pharmacokinetics of drugs in humans.

Hanley MJ, Abernethy DR, Greenblatt DJ. Hanley MJ, et al. Among authors: abernethy dr. Clin Pharmacokinet. 2010;49(2):71-87. doi: 10.2165/11318100-000000000-00000. Clin Pharmacokinet. 2010. PMID: 20067334 Review.

3

Pharmacokinetics and pharmacodynamics of amlodipine.

Abernethy DR. Abernethy DR. Cardiology. 1992;80 Suppl 1:31-6. doi: 10.1159/000175050. Cardiology. 1992. PMID: 1534713

4

Pediatric dose selection.

Abernethy DR, Burckart GJ. Abernethy DR, et al. Clin Pharmacol Ther. 2010 Mar;87(3):270-1. doi: 10.1038/clpt.2009.292. Clin Pharmacol Ther. 2010. PMID: 20160747 Review.

5

Calcium-antagonist drugs.

Abernethy DR, Schwartz JB. Abernethy DR, et al. N Engl J Med. 1999 Nov 4;341(19):1447-57. doi: 10.1056/NEJM199911043411907. N Engl J Med. 1999. PMID: 10547409 Review. No abstract available.

6

IUPHAR International geriatric clinical pharmacology curriculum for medical students.

Kashyap M, Thuermann P, Le Couteur DG, Abernethy DR, Hilmer SN. Kashyap M, et al. Among authors: abernethy dr. Pharmacol Res. 2019 Mar;141:611-615. doi: 10.1016/j.phrs.2019.01.032. Epub 2019 Jan 17. Pharmacol Res. 2019. PMID: 30660820 No abstract available.

7

Metal impurities in food and drugs.

Abernethy DR, Destefano AJ, Cecil TL, Zaidi K, Williams RL; USP Metal Impurities Advisory Panel. Abernethy DR, et al. Pharm Res. 2010 May;27(5):750-5. doi: 10.1007/s11095-010-0080-3. Epub 2010 Mar 9. Pharm Res. 2010. PMID: 20217462 Review.

8

Pharmacological mechanism-based drug safety assessment and prediction.

Abernethy DR, Woodcock J, Lesko LJ. Abernethy DR, et al. Clin Pharmacol Ther. 2011 Jun;89(6):793-7. doi: 10.1038/clpt.2011.55. Epub 2011 Apr 13. Clin Pharmacol Ther. 2011. PMID: 21490594 Review.

9

The utility of modeling and simulation in drug development and regulatory review.

Huang SM, Abernethy DR, Wang Y, Zhao P, Zineh I. Huang SM, et al. Among authors: abernethy dr. J Pharm Sci. 2013 Sep;102(9):2912-23. doi: 10.1002/jps.23570. Epub 2013 May 24. J Pharm Sci. 2013. PMID: 23712632 Review.

10

Tyrosine kinase-targeting drugs-associated heart failure.

Gronich N, Lavi I, Barnett-Griness O, Saliba W, Abernethy DR, Rennert G. Gronich N, et al. Among authors: abernethy dr. Br J Cancer. 2017 May 9;116(10):1366-1373. doi: 10.1038/bjc.2017.88. Epub 2017 Apr 11. Br J Cancer. 2017. PMID: 28399109 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results